Corporate | 14 October 2005 10:00

bmp AG:bmp sells Röntec-shares

Corporate-news transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— Berlin, 14 October 2005 bmp AG announced today that Bruker AXS GmbH, a 100 % subsidiary of the Nasdaq- listed Bruker Biosciences Inc., purchased the 1998 acquired holding of Röntec AG from bmp AG on 10th of October. All other shareholders sold their shares as well. By this disposal bmp achieved satisfying revenue and income. Futhermore bmp reduced its refinancing liabilities to the “Kreditanstalt für Wiederaufbau” (KfW) noticably. “We are glad to find a buyer with Bruker AXS GmbH, who evaluates Röntec AG adequately and who gives the company a promising perspective”, says Stephan Tarlach, the investment manager responsible at bmp AG and member of the supervisory board of Röntec AG. After this sale, which still is under precedent conditions, bmp AG disposes of 19 holdings in the active portfolio. bmp plans additional trade sales and new investments during the current financial year. About bmp: As one of Germany’s leading venture capital companies, bmp directly invests own funds in holdings and, at the same time, acts as a fund manager. With experience gained from more than 80 own holdings, seven stock market flotations as well as more than 20 trade sales from the portfolio, bmp is one of the most competent venture capital companies in Germany and Poland. For further Informationen bmp AG Corinna Riewe Investor Relations Alt-Moabit 59-61 10555 Berlin Tel: 030-20 30 5-567 Fax: 030-20 30 535- 567 Email: criewe@bmp.com Internet: http://www.bmp.com This Corporate News represents neither an offer nor a request for an offer for the purchase of securities to be submitted – especially not in the USA and not in countries or jurisdictions in which an offer, a request for an offer for the purchase of securities to be submitted or the sale of securities would not be permitted under the prevailing Securities Law without prior registration or listing. This Corporate News represents neither an offer for the sale of shares made out to the bearer nor a request for an offer for the purchase of shares to be submitted. It is for information purposes only. End of announcement (c)DGAP 14.10.2005 —————————————————————————— WKN: 330420; ISIN: DE0003304200; Index: Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, München und Stuttgart; Warschau 141000 Okt 05